EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disrupting SARS-CoV-2 Spike–ACE2 Interactions via Glycosaminoglycans in a Pseudoviral Study of Heparan Sulfate and Enoxaparin

Virginia Fuochi iD, Salvatore Furnari iD, Filippo Drago, Pio Maria Furneri iD

Biomolecules · 2025

DOI: 10.3390/biom15070931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Virginia Fuochi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences (Biometec), University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Enoxaparin, Angiotensin-Converting Enzyme 2, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 (coronavirus disease 19) pandemic has underscored the urgent need for effective antiviral agents targeting viral entry mechanisms. This study investigated the inhibitory effects of heparan sulfate (HS) and enoxaparin (EX) on the interaction between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and the angiotensin-converting enzyme 2 (ACE2) receptor.

Methods

A pseudovirus model was employed to evaluate the efficacy of HS and EX under different treatment strategies: pre-treatment of host cells, pre-treatment of the viral particles, and simultaneous co-treatment.

Results

Both compounds significantly inhibited viral entry. EX exhibited a dose-dependent effect under all treatment conditions. In cell pre-treatment, EX achieved the highest levels of inhibition, whereas HS demonstrated consistent inhibitory activity that was largely concentration-independent. Viral pre-treatment revealed that both compounds effectively reduced infectivity by interfering directly with viral particles. In the co-treatment experiments, HS demonstrated superior inhibitory activity at lower concentrations compared to EX.

Conclusions

The results suggested that HS and EX inhibit SARS-CoV-2 entry via distinct mechanisms. HS likely acts via competitive inhibition at the host cell surface, while EX may bind directly to the spike protein, thereby preventing engagement with the ACE2 receptor. These findings highlight the therapeutic potential of HS and EX as entry inhibitors targeting the early stages of SARS-CoV-2 infection. Further studies are warranted to evaluate their efficacy against emerging variants and in vivo models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusEnoxaparinAngiotensin-Converting Enzyme 2SARS-CoV-2Heparan SulfateAntiviral AgentsGlycosaminoglycansHumansVirus InternalizationVero CellsAnimalsChlorocebus aethiopsCOVID-19COVID-19 Drug TreatmentProtein Binding

Stichwörter der Autor:innen

ACE2 receptorSARS-CoV-2enoxaparinglycosaminoglycansheparan sulfatespike proteinviral entry inhibition

Substanzen

Spike Glycoprotein, CoronavirusEnoxaparinAngiotensin-Converting Enzyme 2Heparan SulfateAntiviral AgentsGlycosaminoglycansspike protein, SARS-CoV-2ACE2 protein, human

Autor:innen und Institutionen

  • Department of Biomedical and Biotechnological Sciences (Biometec), University of Catania, 95123 Catania, Italy.

ORCID-Profile: Virginia Fuochi, Salvatore Furnari, Pio Maria Furneri

Förderung

  • Ministero dell'università e della ricerca
  • EU

Zitieren

APA

Fuochi, V., Furnari, S., Drago, F., & Furneri, P. M. (2025). Disrupting SARS-CoV-2 Spike–ACE2 Interactions via Glycosaminoglycans in a Pseudoviral Study of Heparan Sulfate and Enoxaparin. Biomolecules. https://doi.org/10.3390/biom15070931

Vancouver

Fuochi V, Furnari S, Drago F, Furneri PM. Disrupting SARS-CoV-2 Spike–ACE2 Interactions via Glycosaminoglycans in a Pseudoviral Study of Heparan Sulfate and Enoxaparin. Biomolecules. 2025. doi:10.3390/biom15070931

BibTeX
@article{Fuochi2025,
  author = {Fuochi, Virginia and Furnari, Salvatore and Drago, Filippo and Furneri, Pio Maria},
  title = {Disrupting SARS-CoV-2 Spike–ACE2 Interactions via Glycosaminoglycans in a Pseudoviral Study of Heparan Sulfate and Enoxaparin},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15070931}
}
Kostenlos starten →